NEU neuren pharmaceuticals limited

NEU Vs Reata, page-54

  1. 34,438 Posts.
    lightbulb Created with Sketch. 9327
    Biogen generated US$2.9b cash from operating activities, less investing activities of US$154m, net cash inflow was US$2.7B for the 2024 year; net debt of US$3.9B. They would be debt free next year at current pace. It's still very impressive as they paid $7B for Reata.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.81
Change
1.270(10.1%)
Mkt cap ! $1.729B
Open High Low Value Volume
$12.96 $14.00 $12.91 $12.35M 900.0K

Buyers (Bids)

No. Vol. Price($)
5 169 $13.79
 

Sellers (Offers)

Price($) Vol. No.
$13.81 70 1
View Market Depth
Last trade - 14.00pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.